InvestorsHub Logo
Followers 66
Posts 12690
Boards Moderated 0
Alias Born 06/03/2015

Re: sage4 post# 445435

Tuesday, 01/02/2024 9:41:04 PM

Tuesday, January 02, 2024 9:41:04 PM

Post# of 459899
He makes valid points. There is certainly an "improvement" bias in evaluating these young girls, which distorts results.
Comparing blarcamesine efficacy vs. Daybue is indicative of blarcamesine's superiority, with no adverse side effects.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News